Signal from the log
Metabolize
3,2 M$ · Seed · United States
Metabolize, née de travaux de Jonathan Long à Stanford Medicine, transforme des métabolites naturels en produits de santé métabolique grand public. Son premier produit, NATLEAN, prévu en janvier 2027, vise les personnes qui arrêtent un traitement GLP-1. Seed mené par Astanor.
Article
Announced on , logged by the watch of 15 October 2026.
- Operation
- Funding round
- Announced amount
- 3,2 M$
- Stage
- Seed
- Country
- United States
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Astanor , with Maia Ventures , LongGame Venture , SOSV
Provenance
Source prnewswire
Logged on 15 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.